Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Shares Issued (2018 - 2023)

Precision Biosciences (DTIL) has disclosed Shares Issued for 6 consecutive years, with $1000.0 as the latest value for Q4 2023.

  • Quarterly Shares Issued rose 100.0% to $1000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $31000.0 through Dec 2023, down 92.09% year-over-year, with the annual reading at $31000.0 for FY2023, 92.09% down from the prior year.
  • Shares Issued for Q4 2023 was $1000.0 at Precision Biosciences, down from $30000.0 in the prior quarter.
  • The five-year high for Shares Issued was $135.1 million in Q2 2019, with the low at -$133.9 million in Q4 2019.
  • Average Shares Issued over 5 years is $1.6 million, with a median of $198000.0 recorded in 2020.
  • Peak annual rise in Shares Issued hit 217767.74% in 2019, while the deepest fall reached 216106.45% in 2019.
  • Over 5 years, Shares Issued stood at -$133.9 million in 2019, then skyrocketed by 100.15% to $198000.0 in 2020, then soared by 3610.61% to $7.3 million in 2021, then plummeted by 766.3% to -$49.0 million in 2022, then skyrocketed by 100.0% to $1000.0 in 2023.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1000.0, $30000.0, and -$49.0 million for Q4 2023, Q1 2023, and Q4 2022 respectively.